Ace investor Rekha Jhunjhunwala, wife of the late Rakesh Jhunjhunwala, has significantly expanded her investment portfolio by acquiring a substantial stake in Inventurus Knowledge Solutions (IKS). Her latest investment amounts to Rs 13,934.3 crore, thus granting her a commanding 49.3 percent stake in the healthcare solutions firm.
Beyond Rekha Jhunjhunwala’s direct investment, several Jhunjhunwala family trusts have also acquired substantial stakes in IKS such as Aryaman Jhunjhunwala Discretionary Trust – Rs 4,623.2 crore (16.4 percent), Aryavir Jhunjhunwala Discretionary Trust – Rs 4,623.2 crore (16.4 percent) and Nistha Jhunjhunwala Discretionary Trust – Rs 4,623.2 crore (16.4 percent)
Additionally, Rekha Rakesh Jhunjhunwala holds a direct stake worth Rs 64.3 crore (0.2 percent), while RARE Enterprises, where she is a partner, maintains a nominal holding of Rs 32.1 lakh.
It may be recalled that IKS Health made a strong market debut in December, listing at a 43 percent premium to its issue price of Rs 1,329. The stock opened at Rs 1,900 on the NSE and Rs 1,856 on the BSE, reflecting high investor confidence.
However, in recent trading sessions, the stock has experienced a downturn. It is currently priced at Rs 1,651.20, marking a 4.71 percent drop.
IKS Q3 Financial Performance
In its latest quarterly results, IKS Health reported Rs 657.2 crore in revenue, reflecting a 15.9 percent year-on-year (YoY) increase and a 2.2 percent rise quarter-on-quarter (QoQ). The company’s EBITDA stood at Rs 200.6 crore, comprising 30.5 percent of revenue, with a YoY growth of 24.3 percent and a QoQ rise of 5.7%.
The company’s Profit After Tax (PAT) reached Rs 129.7 crore, accounting for 19.7 percent of total revenue. This represents a strong YoY growth of 27.7 percent and a QoQ increase of 14.8 percent, highlighting its financial resilience.
